2017;7:e013685. 29. Cohen JB, Lotito MJ, Trivedi UK, et al. Cardiovascular events and mortality in white coat hypertension: a systematic review and meta- analysis. Ann Intern Med. 2019;170:853 862. 30. Pierdomenico SD, Pierdomenico AM, Coccina F, et al. Prognostic value of masked uncontrolled hypertension. Hypertension. 2018;72:862 869. 31. Shimbo D, Muntner P. Should out-of-of ce monitoring be performed for detecting white coat hypertension? Ann Intern Med. 2019;170:890 892. 32. Ghazi L, Yaffe K, Tamura MK, et al. Association of 24-hour ambulatory blood pressure patterns with cognitive function and physical functioning in CKD. Clin J Am Soc Nephrol. 2020;15:455 464. 33. Minutolo R, Gabbai FB, Borrelli S, et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis. 2007;50:908 917. 34. Mwasongwe SE, Tanner RM, Poudel B, et al. Ambulatory blood pressure phenotypes in adults taking antihypertensive medication with and without CKD. Clin J Am Soc Nephrol. 2020;15:501 510. 35. Pogue V, Rahman M, Lipkowitz M, et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension. 2009;53: 20 27. 36. Siu AL, U.S. Preventative Services Task Force. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163:778 786. 37. Little P, Barnett J, Barnsley L, et al. Comparison of acceptability of and preferences for different methods of measuring blood pressure in primary care. BMJ. 2002;325:258 259. 38. McGowan N, Pad eld PL. Self blood pressure monitoring: a worthy substitute for ambulatory blood pressure? J Hum Hypertens. 2010;24: 801 806. 39. Nasothimiou EG, Karpettas N, Dafni MG, et al. Patients preference for ambulatory versus home blood pressure monitoring. J Hum Hypertens. 2014;28:224 229. 40. Beyhaghi H, Viera AJ. 